skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts

Cutolo, Maurizio ; Ruaro, Barbara ; Montagna, Paola ; Brizzolara, Renata ; Stratta, Emanuela ; Trombetta, Amelia Chiara ; Scabini, Stefano ; Tavilla, Pier Paolo ; Parodi, Aurora ; Corallo, Claudio ; Giordano, Nicola ; Paolino, Sabrina ; Pizzorni, Carmen ; Sulli, Alberto ; Smith, Vanessa ; Soldano, Stefano

2018

Texto completo disponível

Citações Citado por
2
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies

Varian, Frances ; Dick, Jennifer ; Battersby, Christian ; Roman, Stefan ; Ablott, Jenna ; Watson, Lisa ; Binmahfooz, Sarah ; Zafar, Hamza ; Colgan, Gerry ; Cannon, John ; Suntharalingam, Jay ; Lordan, Jim ; Howard, Luke ; McCabe, Colm ; Wort, John ; Price, Laura ; Church, Colin ; Hamilton, Neil ; Armstrong, Iain ; Hameed, Abdul ; Hurdman, Judith ; Elliot, Charlie ; Condliffe, Robin ; Wilkins, Martin ; Webb, Alastair ; Adlam, David ; Benza, Ray L. ; Rahimi, Kazem ; Shojaei‐Shahrokhabadi, Mohadeseh ; Lin, Nan X. ; Wason, James M. S. ; McIntosh, Alasdair ; McConnachie, Alex ; Middleton, Jennifer T. ; Thompson, Roger ; Kiely, David G. ; Toshner, Mark ; Rothman, Alexander

Pulmonary circulation, 2024-01, Vol.14 (1), p.e12337-n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Humbert, Marc ; Kovacs, Gabor ; Hoeper, Marius M ; Badagliacca, Roberto ; Berger, Rolf M F ; Brida, Margarita ; Carlsen, Jørn ; Coats, Andrew J S ; Escribano-Subias, Pilar ; Ferrari, Pisana ; Ferreira, Diogenes S ; Ghofrani, Hossein Ardeschir ; Giannakoulas, George ; Kiely, David G ; Mayer, Eckhard ; Meszaros, Gergely ; Nagavci, Blin ; Olsson, Karen M ; Pepke-Zaba, Joanna ; Quint, Jennifer K ; Rådegran, Göran ; Simonneau, Gerald ; Sitbon, Olivier ; Tonia, Thomy ; Toshner, Mark ; Vachiery, Jean Luc ; Vonk Noordegraaf, Anton ; Delcroix, Marion ; Rosenkranz, Stephan

European heart journal, 2022-10, Vol.43 (38), p.3618-3731 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
4
Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension

Grossman, Madeline ; Walker, Stephen ; Ramsey, E Zachary

Pediatric cardiology, 2024-05 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
Efficacy and safety of non-prostanoid prostacyclin receptor agonist for pulmonary hypertension: A meta-analysis
Efficacy and safety of non-prostanoid prostacyclin receptor agonist for pulmonary hypertension: A meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of non-prostanoid prostacyclin receptor agonist for pulmonary hypertension: A meta-analysis

Wang, Pengwei ; Feng, Hongyan ; Guo, Yongli ; Wu, Nan ; Yin, Honglei ; Zhang, Yongxiang ; Pei, Sujuan ; Gao, Jianlian ; Lu, Yizhong ; Hu, Yang ; Zhang, Yongheng ; Deng, Zhijian

Pulmonary pharmacology & therapeutics, 2023-02, Vol.78, p.102182-102182, Article 102182 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Selexipag for Chronic Thromboembolic Pulmonary Hypertension in Japanese Patients　― A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase II Study
Selexipag for Chronic Thromboembolic Pulmonary Hypertension in Japanese Patients　― A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Selexipag for Chronic Thromboembolic Pulmonary Hypertension in Japanese Patients　― A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase II Study

Tanabe, Nobuhiro ; Fukuda, Keiichi ; Matsubara, Hiromi ; Nakanishi, Norifumi ; Tahara, Nobuhiro ; Ikeda, Satoshi ; Kishi, Takuya ; Satoh, Toru ; Hirata, Ken-ichi ; Inoue, Teruo ; Kimura, Hiroshi ; Okano, Yoshiaki ; Okazaki, Osamu ; Sata, Masataka ; Tsujino, Ichizo ; Ueno, Shuichi ; Yamada, Norikazu ; Yao, Atsushi ; Kuriyama, Takayuki

Circulation Journal, 2020/09/25, Vol.84(10), pp.1866-1874 [Periódico revisado por pares]

Japan: The Japanese Circulation Society

Texto completo disponível

Citações Citado por
7
Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma
Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma

Ma, Guofeng ; Wang, Dan ; Xu, Xiaoling ; Liang, Li ; Xu, Li

Medicine (Baltimore), 2022-07, Vol.101 (28), p.e29412-e29412 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
8
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts

Cutolo, Maurizio ; Ruaro, Barbara ; Montagna, Paola ; Brizzolara, Renata ; Stratta, Emanuela ; Trombetta, Amelia Chiara ; Scabini, Stefano ; Tavilla, Pier Paolo ; Parodi, Aurora ; Corallo, Claudio ; Giordano, Nicola ; Paolino, Sabrina ; Pizzorni, Carmen ; Sulli, Alberto ; Smith, Vanessa ; Soldano, Stefano

Arthritis research & therapy, 2018-05, Vol.20 (1), p.77-77, Article 77 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag:  a case report
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag:  a case report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag:  a case report

Lattanzio, Mariangela ; Ferrari, Marco ; Martini, Stefano ; Ceriani, Francesca ; Imporzani, Andrea ; Marino, Franca ; De Ponti, Roberto ; Cosentino, Marco

Journal of medical case reports, 2022-10, Vol.16 (1), p.1-385, Article 385 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension
Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension

Tanabe, Nobuhiro ; Ikeda, Satoshi ; Tahara, Nobuhiro ; Fukuda, Keiichi ; Hatano, Masaru ; Ito, Hiroshi ; Nakayama, Tomotaka ; Anzai, Toshihisa ; Hashimoto, Akiyoshi ; Inoue, Teruo ; Kajinami, Kouji ; Kihara, Yasuki ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Murohara, Toyoaki ; Okazaki, Osamu ; Sakai, Satoshi ; Satoh, Toru ; Takeda, Yutaka ; Takeishi, Yasuchika ; Taniguchi, Mitsugu ; Watanabe, Hiroshi ; Yamamoto, Takeshi ; Yamauchi-Takihara, Keiko ; Yoshioka, Koichiro ; Sasayama, Shigetake

Circulation Journal, 2017/08/25, Vol.81(9), pp.1360-1367 [Periódico revisado por pares]

Japan: The Japanese Circulation Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (114)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (122)
  2. Book Chapters  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (15)
  2. 1996Até2001  (14)
  3. 2002Até2007  (20)
  4. 2008Até2015  (29)
  5. Após 2015  (47)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (122)
  2. Japonês  (34)
  3. Alemão  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.